Guenther Witzany | Biochemistry, Genetics and Molecular Biology | Excellence in Research Award

Excellence in Research Award

Guenther Witzany
Telos – Philosophische Praxis

Guenther Witzany
Researcher Guenther Witzany
Affiliation Telos – Philosophische Praxis
Country Austria
Scopus ID 14629725000
Documents 29
Citations 288
h-index 11
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Research Excellence and Best Paper Awards

Guenther Witzany, affiliated with Telos – Philosophische Praxis, Austria, is recognized through the Excellence in Research Award for his scholarly contributions to biocommunication theory, evolutionary biology, genetics, and molecular biology. His interdisciplinary work explores communication processes within living systems and advances understanding of biological information exchange. The recognition reflects a sustained publication record, measurable citation impact, and contributions to contemporary scientific discourse within the broader field of molecular and evolutionary sciences.[1]

Abstract

The Excellence in Research Award acknowledges the academic contributions of Guenther Witzany in advancing interdisciplinary understanding of communication processes in living systems. His work integrates concepts from molecular biology, genetics, evolution, and philosophy of science to examine how biological entities generate, exchange, and interpret information. Through publications, theoretical frameworks, and scholarly engagement, Witzany has contributed to discussions concerning biological signaling, genetic regulation, and evolutionary adaptation. His research profile demonstrates sustained productivity, international visibility, and measurable scientific influence, supporting recognition within the International Research Excellence and Best Paper Awards program.[2]

Keywords

Biocommunication, Molecular Biology, Evolutionary Theory, Genetics, Biological Signaling, Scientific Communication, Systems Biology, Research Excellence.

Introduction

Modern biological research increasingly recognizes communication and information exchange as fundamental components of living systems. Guenther Witzany has contributed to this perspective by examining the role of signaling processes across organisms and biological structures. His work bridges scientific and philosophical approaches, offering frameworks that help explain regulatory interactions within genetics, cellular systems, and evolutionary processes. Such interdisciplinary scholarship contributes to broader understanding of biological complexity and adaptive behavior.[3]

Research Profile

Guenther Witzany’s research profile reflects expertise in molecular biology, genetics, evolutionary studies, and theoretical biology. His scholarly activities emphasize communication-based interpretations of biological processes and the significance of information exchange in living organisms. With a documented publication record and international citations, his work contributes to academic discussions regarding the mechanisms through which biological systems coordinate, regulate, and evolve.[1]

Research Contributions

A significant aspect of Witzany’s scholarship involves the development of biocommunication theory, which investigates how organisms employ signs, signals, and contextual interactions. His research highlights the communicative dimensions of cellular activity, genetic regulation, and evolutionary adaptation. These contributions have provided conceptual models used to interpret biological organization beyond purely mechanistic explanations, encouraging interdisciplinary dialogue among researchers from multiple scientific domains.[4]

Publications

  • Biocommunication and Natural Genome Editing.
  • Introduction to Biosemiotics: The New Biological Synthesis.
  • Biocommunication of Fungi.
  • Biocommunication of Plants.
  • Communication and Information Exchange in Evolutionary Systems.

Research Impact

The research impact of Guenther Witzany is reflected through citation performance, continued scholarly engagement, and the adoption of communication-centered perspectives within biological sciences. His publications have contributed to discussions regarding genome regulation, evolutionary innovation, and biological information processing. By encouraging integration between empirical research and conceptual analysis, his work has influenced interdisciplinary investigations across molecular biology and related scientific fields.[2]

Award Suitability

The Excellence in Research Award recognizes sustained scholarly achievement, publication quality, citation influence, and contributions to advancing scientific understanding. Guenther Witzany’s interdisciplinary research portfolio aligns with these criteria through his established record of publications, measurable research impact, and continued engagement with emerging questions in genetics, molecular biology, and evolutionary theory. His work demonstrates both academic rigor and relevance to contemporary scientific inquiry.[5]

Conclusion

Guenther Witzany’s research contributions illustrate the value of interdisciplinary approaches in understanding biological systems. Through investigations of communication, information exchange, and evolutionary processes, he has contributed to scientific discussions that extend across multiple domains of biology. His publication record, citation performance, and conceptual innovations support recognition through the Excellence in Research Award and highlight the continuing relevance of his scholarly work within contemporary life sciences.

References

  1. Elsevier. (n.d.). Scopus author details: Guenther Witzany, Author ID 14629725000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=14629725000
  2. Witzany, G. (2016). The biocommunication method: On the road to an integrative biology. Taylor & Francis.
    https://doi.org/10.1080/19420889.2016.1164374
  3. Witzany, G. (2025). Plant Growth and Development from Biocommunication Perspective. MDPI.
    https://doi.org/10.3390/ijpb16020063
  4. Witzany, G. (2012). Introduction: Keylevels of Biocommunication of Ciliates. Springer.
    https://doi.org/10.1007/978-3-319-32211-7_1
  5. International Research Excellence and Best Paper Awards. (n.d.). Award Evaluation and Recognition Framework.
    https://bestpaperawards.com/

Safa Tahmasebi | Biochemistry | Best Researcher Award | 10070

Dr. Safa Tahmasebi | Biochemistry | Best Researcher Award

PhD of Immunology at Shahid Beheshti University of Medical Sciences | Iran

Dr. Safa Tahmasebi is an accomplished researcher in medical immunology, with expertise in cancer immunotherapy, stem cell biology, exosome research, and immune regulation in infectious and autoimmune diseases. Holding a PhD in Medical Immunology from Shahid Beheshti University of Medical Sciences, she has led and collaborated on numerous impactful projects, including translational research on CAR-T and CAR-NK therapies and novel immunotherapeutic strategies. She has authored multiple publications in high-impact journals indexed in Scopus and PubMed, alongside contributions to books and international congresses where she has delivered invited lectures and top-ranked presentations. Beyond research, she has demonstrated leadership in student research committees, organized academic workshops, and contributed to community platforms. Her achievements reflect strong academic excellence, research innovation, and a commitment to advancing global healthcare through science and education.

Professional Profiles

Google Scholar | Scopus | Orcid

Education

Dr. Safa Tahmasebi has pursued a distinguished academic path in the field of medical sciences, consistently excelling at every stage. She completed her Bachelor’s degree in Laboratory Sciences, achieving first rank throughout her studies. She then earned a Master’s in Medical Immunology, securing top positions in the national entrance examinations, followed by a PhD in Medical Immunology from Shahid Beheshti University of Medical Sciences. During her doctoral studies, she specialized in advanced immunological mechanisms, cancer immunotherapy, and translational medicine, with a strong focus on CAR-T and CAR-NK therapies. Her educational background reflects academic excellence, perseverance, and a deep commitment to scientific advancement. The rigorous training she received has laid a strong foundation for her subsequent professional and research contributions, preparing her to lead innovative projects at both national and international levels.

Experience

Dr. Safa Tahmasebi has gained extensive professional experience as a researcher, educator, and academic leader. She has served as an executive and collaborator in multiple high-impact research projects, including studies on immunotherapy, stem cell applications, exosomes in cancer progression, and immune responses in infectious diseases. Her role extends beyond laboratory research into teaching, where she has conducted theoretical and practical courses in immunology for students in medicine, nursing, pharmacy, and dentistry. She has also organized advanced workshops on systematic reviews, SPSS, ELISA, and cancer immunology, equipping young researchers with essential scientific skills. Additionally, she has been actively involved in student research committees and community platforms, taking leadership roles in guiding scientific initiatives. Through these experiences, she has demonstrated a balance of research innovation, academic mentoring, and community engagement.

Research Interest

Dr. Safa Tahmasebi’s research interests lie at the intersection of immunology, oncology, and translational medicine, with a particular focus on innovative therapeutic strategies. Her primary work involves developing and improving cancer immunotherapies such as CAR-T and CAR-NK cell therapies, investigating tumor microenvironment dynamics, and exploring the roles of exosomes and non-coding RNAs in cancer progression. She is also deeply engaged in studying immune regulation in autoimmune and infectious diseases, including COVID-19, where she has published widely on vaccine responses and immunomodulatory therapies. Her interests extend to anti-aging research, stem cell-based therapies, and the application of artificial intelligence in cancer prediction and treatment. With an emphasis on bridging laboratory research with clinical application, her vision is to advance therapies that significantly improve patient outcomes and contribute to global health solutions.

Awards and Honors

Dr. Safa Tahmasebi has received numerous awards and honors that recognize her academic excellence, research achievements, and community contributions. She has consistently ranked first in national examinations for both her Master’s and PhD programs, highlighting her strong academic foundation. Her achievements include being selected as a model student at both institutional and provincial levels, receiving the National Student Dedication Award for social responsibility, and earning recognition from the National Elite Foundation through multiple Shahid Zazai Projects for top students. She has also been honored as the Outstanding Research Student and selected for the Immunology and Allergy Festival as a leading PhD researcher. These accolades reflect her commitment to scientific excellence, leadership, and service to society, reinforcing her reputation as a highly accomplished and respected young researcher.

Research Skills

Dr. Safa Tahmasebi possesses a comprehensive set of research skills that combine technical expertise with strong analytical and leadership abilities. She is proficient in advanced laboratory techniques such as cell culture, ELISA, flow cytometry, molecular biology methods, and immunological assays. Her expertise extends to systematic reviews, meta-analysis, and the application of statistical tools like SPSS for biomedical research. She has successfully led projects involving experimental models of cancer, immunomodulatory therapies, and exosome-based studies, demonstrating skill in both experimental design and translational application. Additionally, she has significant experience in academic writing, with numerous publications in high-impact journals, books, and conference proceedings. Her ability to lead interdisciplinary projects, collaborate internationally, and mentor students underscores her strengths not only as a researcher but also as an academic leader committed to advancing medical science.

Publication Top Notes

Title: CAR T cells in solid tumors: challenges and opportunities
Year: 2021
Citations: 660

Title: Exosome engineering in cell therapy and drug delivery
Year: 2023
Citations: 250

Title: Recent advances in non-small cell lung cancer targeted therapy; an update review
Year: 2023
Citations: 228

Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
Year: 2021
Citations: 202

Title: Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls
Year: 2020
Citations: 184

Title: The effects of oxygen–ozone therapy on regulatory T‐cell responses in multiple sclerosis patients
Year: 2021
Citations: 171

Title: CAR-T cell combination therapy: the next revolution in cancer treatment
Year: 2022
Citations: 135

Title: Solid tumors challenges and new insights of CAR T cell engineering
Year: 2019
Citations: 122

Title: Immune cell hacking: challenges and clinical approaches to create smarter generations of chimeric antigen receptor T cells
Year: 2018
Citations: 93

Title: CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Year: 2023
Citations: 74

Title: Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2
Year: 2021
Citations: 74

Title: Chimeric antigen receptor-T cell therapy: Applications and challenges in treatment of allergy and asthma
Year: 2020
Citations: 73

Title: Programmable and multi-targeted CARs: a new breakthrough in cancer CAR-T cell therapy
Year: 2020
Citations: 61

Title: The outlook for diagnostic purposes of the 2019‐novel coronavirus disease
Year: 2020
Citations: 49

Title: Study of immunomodulatory effects of mesenchymal stem cell-derived exosomes in a mouse model of LPS induced systemic inflammation
Year: 2022
Citations: 41

Title: Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer
Year: 2022
Citations: 40

Title: Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients
Year: 2020
Citations: 39

Title: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
Year: 2021
Citations: 38

Title: Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation
Year: 2023
Citations: 34

Title: Longevity and anti-aging effects of curcumin supplementation
Year: 2024
Citations: 33

Title: Recent advances in antibody‐based immunotherapy strategies for COVID‐19
Year: 2021
Citations: 33

Title: E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy
Year: 2021
Citations: 32

Title: IL-38 as an early predictor of the ischemic stroke prognosis
Year: 2021
Citations: 30

Title: Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
Year: 2021
Citations: 30

Title: Immune-based therapy for COVID-19
Year: 2021
Citations: 26

Title: Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Year: 2024
Citations: 20

Title: Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function
Year: 2022
Citations: 16

Title: Epigenetic biomarkers in aging and longevity: Current and future application
Year: 2024
Citations: 15

Title: Cellular and biological factors involved in healing wounds and burns and treatment options in tissue engineering
Year: 2022
Citations: 15

Title: Handbook of cancer and immunology
Year: 2022
Citations: 15

Title: Artificial intelligence for prediction of metastasis risk and survival
Year: 2024
Citations: 11

Title: The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease
Year: 2023
Citations: 10

Title: CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies
Year: 2023
Citations: 9

Title: COVID-19: our current knowledge of epidemiology, pathology, therapeutic approaches, and diagnostic methods
Year: 2021
Citations: 9

Title: Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
Year: 2025
Citations: 7

Title: Immunogenicity of COVID‐19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: a systematic review and meta‐analysis
Year: 2023
Citations: 7

Title: Recent innovative approaches to intensify the efficacy and safety of CAR-T cell therapy in cancers
Year: 2022
Citations: 6

Title: Glycolysis and Autoimmune Diseases: A Growing Relationship
Year: 2020
Citations: 6

Title: Harnessing immunotherapy for hepatocellular carcinoma: Principles and emerging promises
Year: 2025
Citations: 5

Title: Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromes
Year: 2024
Citations: 5

Title: The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditions
Year: 2021
Citations: 3

Title: Harnessing the fundamental roles of vitamins: the potent anti-oxidants in longevity
Year: 2025
Citations: 2

Title: Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies
Year: 2025
Citations: 2

Title: Harnessing IL-27: challenges and potential in cancer immunotherapy
Year: 2025
Citations: 2

Title: Anti-aging natural supplements: the main players in promoting healthy lifespan
Year: 2024
Citations: 2

Title: The Assessment of Anti–SARS‐CoV‐2 Antibodies in Different Vaccine Platforms
Year: 2024
Citations: 2

Title: Immunity to tetanus vaccination in pregnant women in Zanjan province, northwest of Iran
Year: 2018
Citations: 2

Title: Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progression
Year: 2025
Citation: 1

Title: CCAT2 role in gastrointestinal cancer progression and metastasis
Year: 2025
Citation: 1

Title: Breaking barriers: CAR-NK cell therapy breakthroughs in female-related cancers
Year: 2025
Citation: 1

Title: DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target
Year: 2025
Citation: 1

Title: Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis
Year: 2025
Citation: 1

Title: Translating preclinical insights into clinical strategies: Targeting cancer stem cells and stemness in prostate cancer
Year: 2025
Citation: 1

Conclusion

In conclusion, Dr. Safa Tahmasebi represents an exceptional example of academic excellence, research innovation, and leadership in the field of medical immunology. With a strong educational foundation, extensive professional experience, and impactful research contributions in cancer immunotherapy, stem cell biology, and immune regulation, she has established herself as a promising scientist. Her awards and honors further demonstrate her commitment to excellence, while her diverse research skills highlight her ability to bridge theory and practice. Through her publications, lectures, and community involvement, she has already made significant contributions to science and society. With her vision for advancing immunological therapies and her ability to inspire and mentor others, she holds immense potential to continue making groundbreaking contributions and is highly deserving of recognition through prestigious research awards.